Adverse events associated with nevirapine use in pregnancy

Abstract excerpt

INTRODUCTION: The risk of adverse drug events associated with nevirapine (NVP) is suggested to be greater in pregnant women. We conducted a systematic review and meta-analysis of severe adverse events in HIV-positive women who initiated NVP while pregnant. METHODS: We searched six databases for studies reporting adverse events among HIV-positive pregnant women who had received NVP-based antiretroviral therapy for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug-Induced Adverse Reactions
• Share to HIV/AIDS drug development and treatment
• Share to Pregnancy and Medication Impact